Natco Pharma (NSE:NATCOPHARM) Pre-Tax Income : ₹16,735 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Natco Pharma's pretax income for the three months ended in Mar. 2024 was ₹4,776 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹16,735 Mil. Natco Pharma's pretax margin was 44.71%.

During the past 13 years, Natco Pharma's highest Pretax Margin was 41.85%. The lowest was 10.61%. And the median was 31.57%.

Natco Pharma Pre-Tax Income Historical Data

The historical data trend for Natco Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Pre-Tax Income Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

5,687.00

5,796.00

2,022.00

8,619.00

16,735.00

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															3,244.00	5,000.00	4,396.00	2,563.00	4,776.00

Competitive Comparison of Natco Pharma's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Pre-Tax Income falls into.

Natco Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Natco Pharma's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	15646	+	0	+	-192	+	0	+	1281
	=	16,735

Natco Pharma's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	4418	+	0	+	-62	+	0	+	420
	=	4,776

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16,735 Mil.

Natco Pharma (NSE:NATCOPHARM) Pre-Tax Income Explanation

Natco Pharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	4776	/	10683
	=	44.71%

During the past 13 years, Natco Pharma's highest Pretax Margin was 41.85%. The lowest was 10.61%. And the median was 31.57%.

Natco Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (NSE:NATCOPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Pre-Tax Income

Traded in Other Exchanges

524816:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (NSE:NATCOPHARM) Headlines

No Headlines